Home
About Us
Featured Products
Oligonucleotide Synthesis Building Blocks
3'-Protected Monomers
5'-DMTr-3'-OH Oligomers
3'-Protected Oligomers
3'-Phosphoramidite Oligomers
Cyclic Dinucleotides
GalNAc
Product Center
Raw Materials
Oligonucleotides
ASOs
siRNAs
miRNAs
Aptamers
CpG Oligonucleotides
Polymers and Lipids for Drug Delivery
Polymers
Phospholipids
Pegylated Lipids
Cationic Lipids
Fluorescent Lipids
Nucleosides and Nucleotides
Nucleosides and Their Analogs
Nucleotides and Their Analogs
Phosphoramidites
Developing Products
For Rare Diseases
For Liver Diseases
For Eye Diseases
For Cardiovascular Diseases
For Cancers
Service Center
ASO Development
siRNA Development
miRNA Development
Aptamer Development
DNAzyme Development
CpG Oligonucleotide Development
TF Decoy Technology Development
Oligonucleotide Synthesis Services
Technology Platforms
Oligonucleotide Synthesis
Solid Phase Oligonucleotide Synthesis
Liquid Phase Oligonucleotide Synthesis
PEG-Based Liquid Phase Synthesis
Non-Polymeric Anchor-Assisted Synthesis
Liquid-Solid Coupled Synthesis
Nonclinical Evaluation
Pharmacodynamic Study
Pharmacokinetic Study
Safety Evaluation
Genotoxicity Evaluation
Immunotoxicity Evaluation
Reproductive Toxicity Evaluation
Safety Pharmacology Evaluation
Delivery Systems
Lipid Conjugate-Based Delivery Systems
GalNAc Conjugate-Based Delivery Systems
Polymeric Nanoparticle-Based Delivery Systems
Peptide Conjugate-Based Delivery Systems
DNA Nanostructure-Based Delivery Systems
Antibody Conjugate-Based Delivery Systems
Small Molecule Conjugate-Based Delivery Systems
Chemical Modification
Backbone Modification
Furanose Sugar Modification
Nucleobase Modification
Sequence Design
Purification and Analysis
Resources
Contact Us
Privacy Policy
Privacy Policy
